05:53 PM EDT, 06/17/2024 (MT Newswires) -- Michael Secora, Chief Financial Officer, on June 13, 2024, sold 30,000 shares in Recursion Pharmaceuticals ( RXRX ) for $278,880. Following the Form 4 filing with the SEC, Secora has control over a total of 1,267,843 shares of the company, with 1,267,843 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1601830/000160183024000083/xslF345X03/wk-form4_1718660802.xml

Price: 9.36, Change: -0.01, Percent Change: -0.11